Using Multicriteria Approaches to Assess the Value of Health Care
- PMID: 28237204
- DOI: 10.1016/j.jval.2016.11.011
Using Multicriteria Approaches to Assess the Value of Health Care
Abstract
Practitioners of cost-utility analysis know that their models omit several important factors that often affect real-world decisions about health care options. Furthermore, cost-utility analyses typically reflect only single perspectives (e.g., individual, business, and societal), further limiting the value for those with different perspectives (patients, providers, payers, producers, and planners-the 5Ps). We discuss how models based on multicriteria analyses, which look at problems from many perspectives, can fill this void. Each of the 5Ps can use multicriteria analyses in different ways to aid their decisions. Each perspective may lead to different value measures and outcomes, whereas no single-metric approach (such as cost-utility analysis) can satisfy all these stakeholders. All stakeholders have unique ways to measure value, even if assessing the same health intervention. We illustrate the benefits of this approach by comparing the value of five different hypothetical treatment choices for five hypothetical patients with cancer, each with different preference structures. Nine attributes describe each treatment option. We add a brief discussion regarding the use of these approaches in group-based decisions. We urge that methods to value health interventions embrace the multicriteria approaches that we discuss, because these approaches 1) increase transparency about the decision process, 2) allow flight simulator-type evaluation of alternative interventions before actual investment or deployment, 3) help focus efforts to improve data in an efficient manner, 4) at least in some cases help facilitate decision convergence among stakeholders with differing perspectives, and 5) help avoid potential cognitive errors known to impair intuitive judgments.
Keywords: multicriteria analysis; priority setting; systems analysis; value modeling.
Copyright © 2017 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.
Similar articles
-
Strategic Planning in Population Health and Public Health Practice: A Call to Action for Higher Education.Milbank Q. 2016 Mar;94(1):109-25. doi: 10.1111/1468-0009.12182. Milbank Q. 2016. PMID: 26994711 Free PMC article.
-
Approaches to Aggregation and Decision Making-A Health Economics Approach: An ISPOR Special Task Force Report [5].Value Health. 2018 Feb;21(2):146-154. doi: 10.1016/j.jval.2017.12.010. Value Health. 2018. PMID: 29477392 Free PMC article.
-
Developing a Value Framework: The Need to Reflect the Opportunity Costs of Funding Decisions.Value Health. 2017 Feb;20(2):234-239. doi: 10.1016/j.jval.2016.11.021. Value Health. 2017. PMID: 28237201
-
Stated and Revealed Preferences for Funding New High-Cost Cancer Drugs: A Critical Review of the Evidence from Patients, the Public and Payers.Patient. 2016 Jun;9(3):201-22. doi: 10.1007/s40271-015-0139-7. Patient. 2016. PMID: 26370257 Review.
-
Can reflective multicriteria be the new paradigm for healthcare decision-making? The EVIDEM journey.Cost Eff Resour Alloc. 2018 Nov 9;16(Suppl 1):54. doi: 10.1186/s12962-018-0116-9. eCollection 2018. Cost Eff Resour Alloc. 2018. PMID: 30455613 Free PMC article. Review.
Cited by
-
The development of the concept of return-on-investment from large-scale quality improvement programmes in healthcare: an integrative systematic literature review.BMC Health Serv Res. 2022 Dec 7;22(1):1492. doi: 10.1186/s12913-022-08832-3. BMC Health Serv Res. 2022. PMID: 36476622 Free PMC article.
-
Synthesis of relevant information around non-core domains to support Multi-Criteria Decision Analysis (MCDA) for decision making.GMS Health Innov Technol. 2024 Mar 27;18:Doc02. doi: 10.3205/hta000139. eCollection 2024. GMS Health Innov Technol. 2024. PMID: 38655192 Free PMC article.
-
Moving Towards Accountability for Reasonableness - A Systematic Exploration of the Features of Legitimate Healthcare Coverage Decision-Making Processes Using Rare Diseases and Regenerative Therapies as a Case Study.Int J Health Policy Manag. 2019 Jul 1;8(7):424-443. doi: 10.15171/ijhpm.2019.24. Int J Health Policy Manag. 2019. PMID: 31441279 Free PMC article.
-
Raise the Bar, Not the Threshold Value: Meeting Patient Preferences for Palliative and End-of-Life Care.Pharmacoecon Open. 2018 Jun;2(2):93-95. doi: 10.1007/s41669-017-0039-y. Pharmacoecon Open. 2018. PMID: 29623615 Free PMC article. No abstract available.
-
Vision for a systems architecture to integrate and transform population health.Proc Natl Acad Sci U S A. 2018 Dec 11;115(50):12595-12602. doi: 10.1073/pnas.1809919115. Proc Natl Acad Sci U S A. 2018. PMID: 30530682 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources